How Deep Brain Stimulation Helps Parkinson’s Patients
The procedure can minimize symptoms and medication dosage to a dramatic effect.
Category: Neurology
UNC teams with Verily Life Sciences to study trauma recovery
The Verily Study Watch will help researchers at the UNC School of Medicine and across the country collect first-in-kind data to better understand and diagnose adverse brain outcomes after trauma.
Chronic Illness, Depression, Neurology, News, Pain, Psychiatry, PTSD, Research, Trauma, Traumatic Brain Injury
UNC research featured in PBS segment on PTSD
PBS NewsHour produced a three-part series on PTSD, including a segment on a research project at the UNC School of Medicine led by Sam McLean, MD.
UNC researchers link orphan receptor to opioid-induced itching
With a more accurate understanding of the characteristics and function of the receptor MRGRPX2, University of North Carolina School of Medicine researchers were also able to create chemical probe that will allow them study the receptor more precisely.
Infant MRIs show autism linked to increased cerebrospinal fluid
MRIs show a brain anomaly in nearly 70 percent of babies at high risk of developing the condition who go on to be diagnosed, laying the groundwork for a predictive aid for pediatricians and the search for a potential treatment.
Researchers uncover brain circuitry central to reward-seeking behavior
Published today in Nature, the discovery has major implications for the study of motivation, decision making, as well as addiction and other disorders.
Scientists illuminate the neurons of social attraction
With a whiff of the opposite sex, these hormone-sensitive neurons trigger pro-social behavior in mice and could play roles in anxiety, depression, and other mood-related conditions in humans.
This is LSD attached to a brain cell serotonin receptor
For the first time, UNC School of Medicine researchers crystalized the structure of LSD attached to a human serotonin receptor of a brain cell, and they may have discovered why an “acid trip” lasts so long.
Brain metastasis persists despite improved targeted treatment for H...
At this year's San Antonio Breast Cancer Symposium, UNC Lineberger researchers and collaborators shared the outcomes of their investigation into the incidence of brain metastasis after a series of drugs were approved to treat HER2-positive metastatic breast cancer, starting with trastuzumab, also known as Herceptin, in the United States in 1998.